Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist

MLA

Jonathan S. Marchant, et al. “Pharmacological Profiling an Abundantly Expressed Schistosome Serotonergic GPCR Identifies Nuciferine as a Potent Antagonist.” International Journal for Parasitology: Drugs and Drug Resistance, vol. 6, Dec. 2016, pp. 364–70. EBSCOhost, https://doi.org/10.1016/j.ijpddr.2016.06.001.

APA

Jonathan S. Marchant, Tim A. Day, Sreemoyee Acharya, & John D. Chan. (2016). Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist. International Journal for Parasitology: Drugs and Drug Resistance, 6, 364–370. https://doi.org/10.1016/j.ijpddr.2016.06.001

Chicago

Jonathan S. Marchant, Tim A. Day, Sreemoyee Acharya, and John D. Chan. 2016. “Pharmacological Profiling an Abundantly Expressed Schistosome Serotonergic GPCR Identifies Nuciferine as a Potent Antagonist.” International Journal for Parasitology: Drugs and Drug Resistance 6 (December): 364–70. doi:10.1016/j.ijpddr.2016.06.001.